Page 169 - MI-2-3

Microbes & Immunity Hyphae and healthspan

disease in pediatric obesity. Nutrients. 2022;14(2):286. pathway and cancer: Why keep it simple when you can make
doi: 10.3390/nu14020286 it complicated. Cancers (Basel). 2022;14(11):2793.
181. Cussotto S, Delgado I, Anesi A, et al. Tryptophan metabolic doi: 10.3390/cancers14112793
pathways are altered in obesity and are associated with 185. Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z.
systemic inflammation. Front Immunol. 2020;11:557. The kynurenine pathway in Alzheimer’s disease: A meta-
doi: 10.3389/fimmu.2020.00557 analysis of central and peripheral levels. Braz J Psychiatry.
2023;45(3):286-297.
182. Mailing LJ, Allen JM, Buford TW, Fields CJ, Woods JA.
Exercise and the Gut microbiome: A review of the evidence, doi: 10.47626/1516-4446-2022-2962
potential mechanisms, and implications for human health. 186. Pallotta MT, Rossini S, Suvieri C, et al. Indoleamine
Exerc Sport Sci Rev. 2019;47(2):75-85. 2,3-dioxygenase 1 (IDO1): An up-to-date overview of an eclectic
doi: 10.1249/JES.0000000000000183 immunoregulatory enzyme. FEBS J. 2022;289(20):6099-6118.
183. Rogiers O, Frising UC, Kucharíková S, et al. Candidalysin doi: 10.1111/febs.16086
crucially contributes to Nlrp3 inflammasome activation by 187. Aburto MR, Cryan JF. Gastrointestinal and brain barriers:
Candida albicans hyphae. mBio. 2019;10(1):e02221-18. Unlocking gates of communication across the microbiota-gut-
doi: 10.1128/mBio.02221-18 brain axis. Nat Rev Gastroenterol Hepatol. 2024;21:222-247.
184. Gouasmi R, Ferraro-Peyret C, Nancey S, et al. The kynurenine doi: 10.1038/s41575-023-00890-0

Volume 2 Issue 3 (2025) 161 doi: 10.36922/mi.4736